Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. (Q50952523)

26 March 2018

title

Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. (English)

1 reference

26 March 2018

chronic renal insufficiency

main subject

1 reference

Jennifer L Ennis

1

1 reference

26 March 2018

Elaine M Worcester

series ordinal

2

1 reference

26 March 2018

Fredric L Coe

series ordinal

3

1 reference

26 March 2018

Stuart M Sprague

series ordinal

4

1 reference

26 March 2018

publication date

4 March 2015

1 reference

26 March 2018

published in

Journal of Nephrology

1 reference

26 March 2018

volume

29

1 reference

26 March 2018

issue

1

1 reference

26 March 2018

page(s)

63-70

1 reference

26 March 2018

https://scigraph.springernature.com/pub.10.1007/s40620-015-0186-0

exact match

0 references

cites work

Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD.

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Vitamin-D deficiency in the osteomalacia of chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Ergocalciferol and cholecalciferol in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Paricalcitol Versus Ergocalciferol for Secondary Hyperparathyroidism in CKD Stages 3 and 4: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Hyperparathyroidism and 1,25-Dihydroxyvitamin D Deficiency in Mild, Moderate, and Severe Renal Failure*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Changes in Serum 25-Hydroxyvitamin D and Plasma Intact PTH Levels Following Treatment With Ergocalciferol in Patients With CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-015-0186-0

Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate?

21 January 2018

1 reference

12 December 2020

Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency.

1 reference

12 December 2020

Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease

1 reference

12 December 2020

Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease

1 reference

12 December 2020

Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure

1 reference

12 December 2020

Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004

1 reference

12 December 2020

Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease

1 reference

12 December 2020

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

1 reference

12 December 2020

Calcium Metabolism in Early Chronic Renal Failure: Implications for the Pathogenesis of Hyperparathyroidism

1 reference

12 December 2020

Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients

1 reference

12 December 2020

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

1 reference

12 December 2020

Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure

1 reference

12 December 2020

10.1007/S40620-015-0186-0

Identifiers

DOI

1 reference

26 March 2018

PubMed ID

25736620

1 reference

26 March 2018